The pressure damage of glaucoma causes a gradual blurring of vision and, if left untreated, can result in total, irreversible blindness. If you suffer from glaucoma, there are several treatment options available. SLT or Selective Laser Trabeculoplasty is a gentle, low-energy laser therapy, which triggers a natural healing response in the eye in order to reduce intraocular pressure. Canaloplasty is an advanced surgical treatment, which works by improving your eye’s natural drainage system.
SLT. The Gentle Alternative for Glaucoma
SLT is a gentle laser therapy, which triggers a natural healing response in the eye to reduce the intraocular pressure associated with glaucoma. It effectively lowers eye pressure in the majority of patients, but the length of time that pressure remains low depends on many factors, including: age and type of glaucoma.
Vitreous Strands and Opacities (Floaters)
If you suffer from vitreous strands and opacities (commonly referred to as “eye floaters”), then you are already familiar with the frustrating visual disturbance caused by these cobweb and cloud-like shadows. A pain-free, non-invasive laser procedure, vitreolysis can provide much-needed relief from your eye floaters – and help you take back your quality of vision.
Age-Related Macular Degeneration (AMD)
A chronic eye disease, AMD is caused by damage to the eye’s macula and can result in vision loss in the central field of vision, including blurred central vision or a blind spot. Early detection is crucial. Detecting changes early through regular check-ups with your optometrist or ophthalmologist can help to slow the progression of AMD.
Diabetic Eye Disease
High blood sugar levels can damage blood vessels in the retina. This damage is referred to as Diabetic Retinopathy. If untreated over the long-term, Diabetic Retinopathy can cause visual impairment and blindness. In order to preserve vision and prevent progression of Diabetic Retinopathy, it is important to take control of your blood sugar levels, blood pressure, and blood cholesterol.